drugset / Trial / NCT02805699

A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema Treatment

NCT02805699 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to confirm the efficacy and safety of BaofeiKang Granule in the treatment of Combined Pulmonary Fibrosis and Emphysema patients.

Timeline

Start
2016-06
Primary completion
2019-06
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Subject BaoFeiKang Granule Unknown 1 unknown Oral